Katherine Bao

7PUBLICATIONS
68CO-AUTHORS
Cardiovascular medicine and haematology not elsewhere classifiedHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular medicineAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Dec 09, 2025
BRUIN CLL-313: Randomized Phase III Trial of Pirtobrutinib Versus Bendamustine Plus Rituximab in Untreated Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.

Wojciech Jurczak, Michal Kwiatek, Jaroslaw Czyz

|Dec 07, 2025
Pirtobrutinib Versus Ibrutinib in Treatment-Naïve and Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.

Jennifer A Woyach, Lugui Qiu, Sebastian Grosicki

|Jun 06, 2025
Phase III Trial of Pirtobrutinib Versus Idelalisib/Rituximab or Bendamustine/Rituximab in Covalent Bruton Tyrosine Kinase Inhibitor-Pretreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BRUIN CLL-321).

Jeff P Sharman, Talha Munir, Sebastian Grosicki

|Jun 08, 2022
Activation-Induced Cytidine Deaminase Impacts the Primary Antibody Repertoire in Naive Mice.

Katherine Bao, Juan Zhang, Alexis Scherl

|Oct 20, 2020
Kinase inhibition in autoimmunity and inflammation.

Ali A Zarrin, Katherine Bao, Patrick Lupardus

|Jun 04, 2020
The kinase IRAK4 promotes endosomal TLR and immune complex signaling in B cells and plasmacytoid dendritic cells.

Cesar A Corzo, Eugene Varfolomeev, A Francesca Setiadi

Pageof 2

Frequent Collaborators

3 joint publications

Ali A Zarrin

2 joint publications

Wyne P Lee

2 joint publications

Anna Panovská

2 joint publications

Tomasz Wrobel